Paragonix Technologies offers solutions for organ transplantation, providing support for members of the transplant community.

Paragonix

Paragonix Technologies is a rapidly growing medical device manufacturer that designs, manufactures, and sells organ transplant transport devices. Our dynamic team is committed to improving the lives of transplant patients by providing advanced technologies to ensure optimal preservation for donor organs on the journey to their ultimate recipients. Our primary offices are located in Waltham, MA.

Paragonix Technologies, Inc.

Are you looking to join the team at Paragonix? Explore new opportunities on our career page today! 

We're on the lookout for a Sales Operations Specialist to contribute to our daily operations. The ideal candidate will be a proactive self-starter and a collaborative team player with strong communication skills. This dynamic role involves working closely with leadership to maintain accurate data records and streamline daily processes. 

Apply now and discover more about this exciting opportunity: https://lnkd.in/g9gpUcmu

#hiring #jobopportunity #salesops

📢 We're accepting abstracts for #ISHLT2025! 📖 💡  We want your science in the treatment of advanced #heart and #lung disease, transplantation, and #MCS. Visit 🔗 https://bit.ly/3WNkEqX to learn more and get started.

Pushing the historical limits to break new barriers!

Dr. Fiedler is always a fantastic speaker - really loved getting to hear her unique perspective when she joined as a guest on the Paragonix podcast. Well worth a watch! https://lnkd.in/eAxWw-XB
#everypossibleangle

Study of more than 1200 heart-transplant recipients from the GUARDIAN-Heart Registry finds that a simple, static cold storage preservation system significantly extends safe out-of-body time for heart allografts.

🔗: https://lnkd.in/giCjP7wu

David D'Alessandro, Jacob Schroder, Dan Meyer, Scott Silvestry, MARZIA LEACCHE, Si Pham, Hannah Copeland, Kawabori Masashi, Koji Takeda, Andreas Zuckermann

The Texas Transplantation Society, Inc.'s annual scientific meeting was one of the best ways to wrap up the month. It was an honor to share our latest innovations at a conference dedicated to cutting-edge advancements across the landscape of transplantation.

Thank you for representing the Paragonix team, Amy!

Interested in learning the latest from the Journal of Heart and Lung Transplantation? 

Check out the last episode of the JHLT Podcast, featuring lead GUARDIAN-Heart investigator, Dr. David D'Alessandro, first author on the GUARDIAN study featuring 1-year clinical outcomes of advanced hypothermic preservation with the SherpaPak CTS. 

"We looked at the difference in curves of risk of severe PGD as a function of ischemic time," Dr. D'Alessandro shared. "At all time points, ice is at higher risk of PGD than this system. Now, at lower ischemic times of two hours, the risk of severe PGD with ice is pretty low...but it's even lower with this device."

Learn more about the GUARDIAN manuscript, or listen to the interview at: https://lnkd.in/g6kt82ft

COM:PARAGONIXTECHNOLOGIES

Paragonix